How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment

Neurophysiologie Clinique

Volumn 41, Issue 3, 2011, Pages 115-123

  Campanella, S ^a   Petit, G ^a   Verbanck, P ^a   Kornreich, C ^a   Noel, X ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Acamprosate; Alcohol dependence; Cognitive neuropsychiatry; ERPs; Naltrexone

Indexed keywords

ACAMPROSATE; NALTREXONE; PLACEBO; PROTEIN P100; PROTEIN P300;

ALCOHOLISM; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE THERAPY; DETOXIFICATION; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; ENDOPHENOTYPE; EVENT RELATED POTENTIAL; EVOKED VISUAL RESPONSE; HUMAN; LATENT PERIOD; NONHUMAN; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; REVIEW; TREATMENT DURATION; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

EID: 79960605778     PISSN: 09877053     EISSN: 17697131     Source Type: Journal    
DOI: 10.1016/j.neucli.2011.04.001     Document Type: Short Survey

References (65)

1. Alfonso JP, Caracuel A, Delgado-Pastor LC, Verdejo-García A. Combined goal management training and mindfulness meditation improve executive functions and decision-making performance in abstinent polysubstance abusers. Drug Alcohol Depend 2011, (in press). doi:10.1016/j.drugalcdep.2010.12.025.
2. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington, DC.
3. Diagnostic and statistical manual of mental disorders DSM-IV-TR (Text revision) 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC.
4. Amir N., Weber G., Beard C., Bomyea J., Taylor C.T. The effect of a single-session attention modification program on response to a public-speaking challenge in socially anxious individuals. J Abnorm Psychol 2008, 117(4):860-868.
5. Anton R.F. Naltrexone for the management of alcohol dependence. New Engl J Med 2008, 359(7):715-721.
6. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The Combine study: a randomized controlled trial. JAMA 2006, 295:2003-2017.
7. Begleiter H., Porjesz B. What is inherited in the predisposition toward alcoholism? A proposed model. Alcohol Clin Experiment Res 1999, 23(7):1125-1135.
8. Begleiter H., Porjesz B., Bihari B., Kissin B. Event related brain potentials in boys at risk for alcoholism. Science 1984, 225:1493-1496.
9. Boettiger C.A., Kelley E.A., Mitchell J.M., D'Esposito M., Fields H.L. Now or later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacol Biochem Behav 2009, 93(3):291-299.
10. Bouza C., Magro A., Munoz A., Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004, 99:811-828.
11. Campanella S., Petit G., Maurage P., Kornreich C., Verbanck P., Noël X. Chronic alcoholism: insights from neurophysiology. Neurophysiol Clin /Clin Neurophysiol 2009, 39:191-207.
12. Chambers R., Taylor J., Potenza M. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003, 160:1041-1052.
13. Cox W., Hogan L., Kristian M., Race J. Alcohol atentional bias as a predictor of alcohol abusers' treatment outcome. Drug Alcohol Depend 2002, 68:237-243.
14. Deutsch R., Fritz S. Reflective and impulsive determinants of addictive behavior. Handbook of implicit cognition and addiction 2006, Sage Press, Thousand Oaks, CA: Sage, 550 p. W. Reinout, W.S. Alan (Eds.).
15. Evans J. In two minds: dual process accounts of reasoning. Trends Cogn Sci 2003, 7:454-459.
16. Field M., Mogg K., Zetteler J., Bradley B. Attention biases for alcohol cues in heavy and light social drinkers: the roles of initial orienting and maintained attention. Psychopharmacology 2004, 176:105-111.
17. Fillmore M. Drug abuse as a problem of impaired control: current approaches and findings. Behav Cogn Neurosci Rev 2003, 2(3):179-197.
18. Fillmore M. Acute alcohol-induced impairment of cognitive functions: past and present findings. Int J Disabil Human Develop 2007, 6:115-125.
19. Finney J.W., Hahn A.C., Moos R.H. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 1996, 91:1773-1796.
20. Fuller R.K., Gordis E. Naltrexone treatment for alcohol dependence. New Engl J Med 2001, 345:1770-1771.
21. Hammarberg A., Jayaram-Lindström N., Beck O., Franck J., Reid M.S. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial. Psychopharmacology 2009, 205:53-62.
22. Johnsen B., Laberg J., Cox W., Vaksdal A., Hugdahl Alcoholic subjects' attentional bias in the processing of alcohol-related words. Psychol Addict Behav 1994, 8:111-115.
23. Johnson B.A. Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Alcohol Clin Exp Res 2004, 28:1137-1144.
24. Johnson B.A. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 2008, 75(1):34-56.
25. Kaiser S., Unger J., Kiefer M., Markela J., Mundt C., Weisbrod M. Executive control defi{ligature}cit in depression: event-related potentials in a Go/Nogo task. Psychiatr Res 2003, 122:169-184.
26. Kamarajan C., Porjesz B., Jones K., Choi K., Chorlian D., Padmanabhapillai A., et al. Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task. Biol Psychol 2005, 69(3):353-373.
27. Kenna G.A., Lomastro T.L., Schiesl A., Leggio L., Swift R.M. Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev 2009, 2:135-142.
28. Levaux M.N., Vezzaro J., Laroi F., Offerlin-Meyer I., Danion J.M., Van der Linden M. Cognitive rehabilitation of the updating sub-component of working memory in schizophrenia: a case study. Neuropsychol Rehabil 2008, 19:244-273.
29. Levine B., Robertson I.H., Clare L., Carter G., Hong J., Wilson B.A., et al. Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc 2000, 6(3):299-312.
30. Lindholm J., Guitart-Masip M., Hassankhali H., Landgren S., Nicoleau C., Giménez-Llort L., et al. Effects of naltrexone and acamprosate on alcohol-induced NGFI-A expression in mouse brain. Neurochem Res 2008, 33(10):2062-2069.
31. Loeber S., Vollstädt-Kein S., von der Goltz C., Flor H., Mann K., Keifer F. Attentional bias in alcohol-depenent patients the role of chronicity and executive functioning. Addict Biol 2009, 14:194-203.
32. Luck S.J., Woodman G.F., Vogel E.K. Event-related potential studies of attention. Trends Cogn Sci 2000, 4:432-440.
33. Mann K., Hermann D. Individualised treatment in alcohol-dependent patients. Eur Arch Psychiatr Clin Neurosci 2010, 260:116-120.
34. Mann K., Kiefer F., Smolka M., Gann H., Wellek S., Heinz A. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the predict study. Alcohol Clin Experiment Res 2009, 33(4):674-683. the PREDICT study research team.
35. Mason B. Rationale for combining acamprosate and naltrexone for treating alcohol dependence. J Stud Alcohol 2005, Suppl. 15:148-156.
36. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic mental illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
37. Morley K.C., Teesson M., Reid S.C., Sannibale C., Thomson C., Phung N., et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multicentre, randomized, double-blind, placebo-controlled trial. Addiction 2006, 101(10):1451-1462.
38. Nicolas J.M., Estruch R., Salamero M., Orteu N., Fernandez-Sola J., Sacanella E., et al. Brain impairment in well-nourished chronic alcoholics is related to ethanol intake. Ann Neurol 1997, 41(5):590-598.
39. Noël X., Campanella S., Pelc I., Verbanck P. Acute and chronic effects of alcohol: some insights from cognitive sciences. Acta Clin Belgica 2010, 65(Suppl. 1):68-74.
40. Noël X., Colmant M., Van der Linden M., Bechara A., Bullens Q., Hanak C., et al. Time course of attention for alcohol cues in abstinent alcoholic patients: the role of initial orienting. Alcohol Clin Experiment Res 2006, 30(11):1871-1877.
41. Noël X., Van der Linden M., d'Acremont M., Colmant M., Hanak C., Pelc I., et al. Cognitive biases towards alcohol-related words and executive deficits in polysubstance abusers with alcoholism. Addiction 2005, 100:1302-1309.
42. Noël X., Van der Linden M., Schmidt N., Sferrazza R., Hanak C., Le Bon O., et al. Supervisory attentional system in non-amnesic alcoholic men. Arch Gen Psychiatry 2001, 58(12):1152-1158.
43. Northoff G. Neuropsychiatry. An old discipline in a new gestalt bridging biological psychiatry, neuropsychology, and cognitive neurology. Eur Arch Psychiatry Clin Neurosci 2008, 258(4):226-238.
44. Ooteman W., Koeter M.W., Verheul R., Schippers G.M., van den Brink W. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 2007, 17(8):558-566.
45. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007, 118(10):2128-2148.
46. Pourtois G., Thut G., Grave de Peralta R., Michel C., Vuilleumier P. Two electrophysiological stages of spatial orienting towards fearful faces: early temporoparietal activation preceding gain control in extrastriate visual cortex. NeuroImage 2005, 26:149-163.
47. Richardson K., Baillie A., Reid S., Morley K., Teesson M., Sannibale C., et al. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?. Addiction 2008, 103(6):953-959.
48. Robertson I.H. Goal management training: a clinical manual 1996, PsyConsult, Cambridge, UK.
49. Robinson T., Berridge K. Addiction. Ann Rev Psychol 2003, 54:25-53.
50. Rubio G., Jiménez-Arriero M.A., Ponce G., Palomo T. Naltrexone versus acamprosate: 1-year follow-up of alcohol dependence treatment. Alcohol Alcohol 2001, 36(5):419-425.
51. Rugg M.D., Coles M.G.H. Electrophysiology of mind. Event-related brain potentials and cognition 1995, Oxford University Press, Oxford Psychology Series, Oxford.
52. Sablier J., Stip E., Franck N. Cognitive remediation and cognitive assistive technologies in schizophrenia. Encephale 2009, 35:160-167.
53. Seeck M., Michel C.M., Mainwaring N., Cosgrove R., Blume H., Ives J., et al. Evidence for rapid face recognition from human scalp and intracranial electrodes. Neuroreport 1997, 8:2749-2754.
54. Sinclair J.D. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 2001, 36:2-10.
55. Skinner M.D., Aubin H.J. Craving's place in addiction theory: contributions of the major models. Neurosci Biobehav Rev 2010, 34(4):606-623.
56. Smith J.L., Johnstone S.J., Barry R.J. Effects of prestimulus processing on subsequent events in a warned Go/NoGo paradigm: response preparation, execution and inhibition. Int J Psychophysiol 2006, 61:121-133.
57. Snyder J.L., Bowers T.G. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Am J Drug Alcohol Abuse 2008, 34(4):449-461.
58. Squires N.K., Squires K.C., Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephal Clin Neurophysiol 1975, 38:387-401.
59. Stacy A.W., Wiers R.W. Implicit cognition and addiction: a tool for explaining paradoxical behavior. Ann Rev Clin Psychol 2010, 27:551-575.
60. Steriade M., Gloor P., Llinas R.R., Lopes de Silva F.H., Mesulam M.M. Report of IFCN committee on basic mechanisms. Basic mechanisms of cerebral rhythmic activities. Electroencephal Clin Neurophysiol 1990, 76:481-508.
61. Swift R.M. Topiramate for the treatment of alcohol dependence: initiating abstinence. Lancet 2003, 361:1666-1667.
62. Taylor M.J., Khan S.C. Top-down modulation of early selective attention processes in children. Int J Psychophysiol 2000, 37:135-147.
63. Tomberg C., Desmedt J.E. Human perceptual processing: inhibition of transient prefrontal-parietal 40Hz binding at P300 onset documented in non-averaged cognitive brain potentials. Neurosci Lett 1998, 255(3):163-166.
64. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992, 49:876-880.
65. Weafer J., Fillmore M. Individual differences in acute alcohol impairment of inhibitory control predict ad libitum alcohol consumption. Psychopharmacology 2008, 201:315-324.